Growth Metrics

Myriad Genetics (MYGN) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to $2.8 million.

  • Myriad Genetics' Other Working Capital Changes rose 1200.0% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 6333.33%. This contributed to the annual value of $3.7 million for FY2024, which is 1590.91% down from last year.
  • According to the latest figures from Q3 2025, Myriad Genetics' Other Working Capital Changes is $2.8 million, which was up 1200.0% from -$1.9 million recorded in Q2 2025.
  • Myriad Genetics' 5-year Other Working Capital Changes high stood at $6.6 million for Q4 2022, and its period low was -$11.7 million during Q2 2021.
  • Over the past 5 years, Myriad Genetics' median Other Working Capital Changes value was $450000.0 (recorded in 2022), while the average stood at -$761111.1.
  • Data for Myriad Genetics' Other Working Capital Changes shows a peak YoY increase of 115000.0% (in 2021) and a maximum YoY decrease of 176666.67% (in 2021) over the last 5 years.
  • Over the past 5 years, Myriad Genetics' Other Working Capital Changes (Quarter) stood at -$6.2 million in 2021, then soared by 206.45% to $6.6 million in 2022, then crashed by 78.79% to $1.4 million in 2023, then crashed by 164.29% to -$900000.0 in 2024, then soared by 411.11% to $2.8 million in 2025.
  • Its Other Working Capital Changes was $2.8 million in Q3 2025, compared to -$1.9 million in Q2 2025 and $2.2 million in Q1 2025.